TSE:HSM

Helius Medical Technologies Competitors

C$21.63
+0.20 (+0.93 %)
(As of 04/21/2021 12:00 AM ET)
Add
Compare
Today's Range
C$21.63
Now: C$21.63
C$22.00
50-Day Range
C$15.88
MA: C$19.74
C$22.86
52-Week Range
C$14.00
Now: C$21.63
C$40.00
Volume700 shs
Average Volume5,996 shs
Market CapitalizationC$49.99 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Competitors

Helius Medical Technologies (TSE:HSM) Vs. VMD, TMD, HTL, PTQ, PHM, and ASG

Should you be buying HSM stock or one of its competitors? Companies in the industry of "medical devices" are considered alternatives and competitors to Helius Medical Technologies, including Viemed Healthcare (VMD), Titan Medical (TMD), Hamilton Thorne (HTL), Protech Home Medical (PTQ), Protech Home Medical (PHM), and Aurora Spine (ASG).

Helius Medical Technologies (TSE:HSM) and Viemed Healthcare (TSE:VMD) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, risk, dividends, analyst recommendations, institutional ownership, profitability and earnings.

Earnings and Valuation

This table compares Helius Medical Technologies and Viemed Healthcare's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Helius Medical TechnologiesC$661,000.0075.62C$-34,262,886.00C($14.83)-1.46
Viemed HealthcareC$131.31 million3.53C$38.61 millionC$0.9812.02

Viemed Healthcare has higher revenue and earnings than Helius Medical Technologies. Helius Medical Technologies is trading at a lower price-to-earnings ratio than Viemed Healthcare, indicating that it is currently the more affordable of the two stocks.

Profitability

This table compares Helius Medical Technologies and Viemed Healthcare's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Helius Medical TechnologiesN/AN/AN/A
Viemed HealthcareN/AN/AN/A

Analyst Recommendations

This is a summary of recent recommendations and price targets for Helius Medical Technologies and Viemed Healthcare, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Helius Medical Technologies0000N/A
Viemed Healthcare01002.00

Summary

Viemed Healthcare beats Helius Medical Technologies on 4 of the 5 factors compared between the two stocks.

Titan Medical (TSE:TMD) and Helius Medical Technologies (TSE:HSM) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, profitability, earnings, institutional ownership, analyst recommendations, valuation and dividends.

Profitability

This table compares Titan Medical and Helius Medical Technologies' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Titan MedicalN/AN/AN/A
Helius Medical TechnologiesN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for Titan Medical and Helius Medical Technologies, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Titan Medical00103.00
Helius Medical Technologies0000N/A

Valuation & Earnings

This table compares Titan Medical and Helius Medical Technologies' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Titan MedicalC$20 million10.84C$-49,505,300.00C($0.45)-4.38
Helius Medical TechnologiesC$661,000.0075.62C$-34,262,886.00C($14.83)-1.46

Helius Medical Technologies has lower revenue, but higher earnings than Titan Medical. Titan Medical is trading at a lower price-to-earnings ratio than Helius Medical Technologies, indicating that it is currently the more affordable of the two stocks.

Helius Medical Technologies (TSE:HSM) and Hamilton Thorne (CVE:HTL) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations and risk.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Helius Medical Technologies and Hamilton Thorne, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Helius Medical Technologies0000N/A
Hamilton Thorne00403.00

Hamilton Thorne has a consensus target price of C$1.87, indicating a potential upside of 7.47%. Given Hamilton Thorne's higher possible upside, analysts clearly believe Hamilton Thorne is more favorable than Helius Medical Technologies.

Profitability

This table compares Helius Medical Technologies and Hamilton Thorne's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Helius Medical TechnologiesN/AN/AN/A
Hamilton ThorneN/AN/AN/A

Earnings and Valuation

This table compares Helius Medical Technologies and Hamilton Thorne's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Helius Medical TechnologiesC$661,000.0075.62C$-34,262,886.00C($14.83)-1.46
Hamilton ThorneC$39.78 million6.08C$1.25 millionC$0.01193.33

Hamilton Thorne has higher revenue and earnings than Helius Medical Technologies. Helius Medical Technologies is trading at a lower price-to-earnings ratio than Hamilton Thorne, indicating that it is currently the more affordable of the two stocks.

Summary

Hamilton Thorne beats Helius Medical Technologies on 6 of the 7 factors compared between the two stocks.

Helius Medical Technologies (TSE:HSM) and Protech Home Medical (CVE:PTQ) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their dividends, valuation, profitability, earnings, institutional ownership, analyst recommendations and risk.

Analyst Recommendations

This is a breakdown of current ratings and price targets for Helius Medical Technologies and Protech Home Medical, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Helius Medical Technologies0000N/A
Protech Home Medical00503.00

Protech Home Medical has a consensus target price of C$2.58, indicating a potential upside of 20.16%. Given Protech Home Medical's higher possible upside, analysts clearly believe Protech Home Medical is more favorable than Helius Medical Technologies.

Profitability

This table compares Helius Medical Technologies and Protech Home Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Helius Medical TechnologiesN/AN/AN/A
Protech Home MedicalN/AN/AN/A

Earnings and Valuation

This table compares Helius Medical Technologies and Protech Home Medical's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Helius Medical TechnologiesC$661,000.0075.62C$-34,262,886.00C($14.83)-1.46
Protech Home MedicalC$82.22 million2.95C$-5,417,568.00C($0.05)-44.79

Protech Home Medical has higher revenue and earnings than Helius Medical Technologies. Protech Home Medical is trading at a lower price-to-earnings ratio than Helius Medical Technologies, indicating that it is currently the more affordable of the two stocks.

Summary

Protech Home Medical beats Helius Medical Technologies on 5 of the 7 factors compared between the two stocks.

Helius Medical Technologies (TSE:HSM) and Protech Home Medical (CVE:PHM) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Profitability

This table compares Helius Medical Technologies and Protech Home Medical's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Helius Medical TechnologiesN/AN/AN/A
Protech Home MedicalN/AN/AN/A

Valuation & Earnings

This table compares Helius Medical Technologies and Protech Home Medical's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Helius Medical TechnologiesC$661,000.0075.62C$-34,262,886.00C($14.83)-1.46
Protech Home MedicalC$77.14 million0.62C$833,022.00C$0.0057.50

Protech Home Medical has higher revenue and earnings than Helius Medical Technologies. Helius Medical Technologies is trading at a lower price-to-earnings ratio than Protech Home Medical, indicating that it is currently the more affordable of the two stocks.

Analyst Recommendations

This is a summary of current recommendations for Helius Medical Technologies and Protech Home Medical, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Helius Medical Technologies0000N/A
Protech Home Medical0000N/A

Summary

Protech Home Medical beats Helius Medical Technologies on 4 of the 5 factors compared between the two stocks.

Helius Medical Technologies (TSE:HSM) and Aurora Spine (CVE:ASG) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Analyst Recommendations

This is a summary of current recommendations for Helius Medical Technologies and Aurora Spine, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Helius Medical Technologies0000N/A
Aurora Spine0000N/A

Profitability

This table compares Helius Medical Technologies and Aurora Spine's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Helius Medical TechnologiesN/AN/AN/A
Aurora SpineN/AN/AN/A

Valuation & Earnings

This table compares Helius Medical Technologies and Aurora Spine's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Helius Medical TechnologiesC$661,000.0075.62C$-34,262,886.00C($14.83)-1.46
Aurora SpineC$8.84 million4.95C$-1,052,790.00C($0.02)-41.58

Aurora Spine has higher revenue and earnings than Helius Medical Technologies. Aurora Spine is trading at a lower price-to-earnings ratio than Helius Medical Technologies, indicating that it is currently the more affordable of the two stocks.

Summary

Aurora Spine beats Helius Medical Technologies on 3 of the 5 factors compared between the two stocks.


Helius Medical Technologies Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
VMD
Viemed Healthcare
0.3$11.73+0.7%C$464.06 millionC$131.31 million12.02
TMD
Titan Medical
0.8$1.98+6.6%C$216.86 millionC$20 million-4.38Analyst Report
News Coverage
Hamilton Thorne logo
HTL
Hamilton Thorne
1.2$1.74+0.6%C$165.83 millionC$39.78 million193.33
Protech Home Medical logo
PTQ
Protech Home Medical
1.2$2.15+2.8%C$94.56 millionC$82.22 million-44.79
PHM
Protech Home Medical
0.5$0.12+4.3%C$50.12 millionC$77.14 million57.50Gap Up
ASG
Aurora Spine
0.6$0.79+2.5%C$8.31 millionC$8.84 million-41.58Gap Up
BLO
Cannabix Technologies
0.5N/AN/AC$0.00N/A0.00Gap Up
ORTH
Ortho Regenerative Technologies
0.5N/AN/A$0.00N/A0.00High Trading Volume
Smith & Nephew logo
SNN
Smith & Nephew
0.6N/AN/A$0.00N/A0.00
VMD
Viemed Healthcare
0.5$4.95+2.0%C$0.00N/A0.00Gap Up
This page was last updated on 4/21/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.